DBISX | MBXIX | DBISX / MBXIX | |
Total Expense Ratio | 1.34 | 2.03 | 66% |
Annual Report Gross Expense Ratio | 1.34 | 2.03 | 66% |
Fund Existence | 25 years | 10 years | - |
Gain YTD | 14.132 | 4.817 | 293% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 173M | 8.45B | 2% |
Annual Yield % from dividends | 1.80 | 1.82 | 99% |
Returns for 1 year | 10.49 | 5.78 | 181% |
Returns for 3 years | 31.21 | 8.25 | 378% |
Returns for 5 years | 31.95 | 53.81 | 59% |
Returns for 10 years | 64.25 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYBOX | 66.17 | 1.17 | +1.80% |
Rydex Biotechnology A | |||
LRSSX | 15.27 | 0.27 | +1.80% |
Lord Abbett Small Cap Value R4 | |||
AFDCX | 54.56 | 0.55 | +1.02% |
American Century Large Cap Equity C | |||
DFIEX | 19.63 | 0.14 | +0.72% |
DFA International Core Equity 2 I | |||
MXECX | 11.54 | 0.08 | +0.70% |
Empower Core Strategies Intl Eq Instl |